Nanotechnology offers precise drug delivery systems that can improve the efficacy and reduce the side effects of senolytic therapies. Nanocarriers, such as liposomes, micelles, and dendrimers, can be engineered to specifically target senescent cells, ensuring that the senolytic agents are delivered exactly where they are needed.
